Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditions

Garry M Walsh

Research output: Contribution to journal › Article › peer-review

61 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Reslizumab, a humanized anti-IL-5 mAb for the treatment of eosinophil-mediated inflammatory conditions'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds